With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.
- Third Harmonic Bio, Inc. THRD will be trading publicly starting on Sept. 15, 2022. The company’s price band is set between $16 and $18 with an insider lock-up period of 180 days. Third Harmonic Bio, Inc. will be offering 9,000,000 shares at a per-share value of $17.
- Corebridge Financial, Inc. CRBG becomes publicly listed starting on Sept. 15, 2022. The company has a price range set between $21 and $24 with a 180-day lockup period. Corebridge Financial, Inc. will be offering 80,000,000 shares at a per-share value of $22.50.
- Jupiter Neurosciences, Inc JUNS will be trading publicly starting on Sept. 14, 2022. The company’s price band is set between $5 and $7 with an insider lock-up period of 180 days. Jupiter Neurosciences, Inc will be offering 2,500,000 shares at a per-share value of $6.
- Lichen China Limited LICN will be trading publicly starting on Sept. 12, 2022. Lichen China Limited will be offering 6,250,000 shares at a per-share value of $4 with an insider lock-up period of 180 days.
Initial public offerings, or IPOs, are the transitional processes of private companies deciding to go public and offer shares to investors on exchanges. IPOs typically offer companies the ability to build capital by distributing shares across the market. A company interested in becoming publicly tradeable must first meet SEC requirements and work with investment banks through audits to determine pricing, offering date, and other important data points before the offering.
Companies and investment banks will work to establish a price range that the stock is expected to sell between. This is known as an offering range. Once a company goes public, its stock comes with an opening price. The insider lock-up period is usually a set number of days after an IPO where company insiders, or employees with a 10% or higher stake in their company, cannot sell shares.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.